Literature DB >> 15858170

Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.

Ewa Maria Koźma1, Krystyna Olczyk, Grzegorz Wisowski, Andrzej Głowacki, Rafał Bobiński.   

Abstract

Dupuytren's disease is a palmar fibromatosis associated with changes in fibroblast activity that also affect the metabolism of extracellular matrix components. In contrast to disease connected alterations in collagen and non-collagenous glycoproteins (mainly fibronectin), the metabolism of proteoglycans, being glycosaminoglycan modified glycoproteins, is poorly understood. Thus, the aim of the present study was the characterization of matrix proteoglycans (PGs) derived from normal fascia and Dupuytren's fascia. Extracted and purified PGs (particularly small PGs) were analysed for content, molecular mass, immunoreactivity and glycosaminoglycan chain structure. The matrix of normal fascia mainly contains decorin [small dermatan sulfate (DS) PG] with biglycan (another small DSPG) and large chondroitin sulfate(CS)/DSPG representing minor components. Dupuytren's disease is associated with the remodeling of matrix PG composition. The most prominent alteration is an accumulation of biglycan frequently bearing DS chains with higher molecular masses. Moreover, the amount of large CS/DSPG is increased. In contrast, decorin displays changes affecting mainly DS chain structure reflected in (i) an increase in some chain molecular masses, (ii) an enhanced content of iduronate disaccharide clusters, and (iii) oversulfation of disaccharide repeats. The PG alterations observed in Dupuytren's fascia may influence the matrix properties and contribute to disease progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858170     DOI: 10.1093/jb/mvi054

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

Review 1.  The fascia of the limbs and back--a review.

Authors:  Mike Benjamin
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

2.  The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence.

Authors:  Linda Vi; Bing Siang Gan; David B O'Gorman
Journal:  Med Hypotheses       Date:  2009-11-05       Impact factor: 1.538

3.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 4.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

5.  GLYCOSAMINOGLYCANS AND PROTEOGLYCANS IN PALMAR FASCIA OF PATIENTS WITH DUPUYTREN.

Authors:  Priscilla Carneiro Hirai Nascimento; Elsa Yoko Kobayashi; Luiz Guilherme de Saboya Lenzi; João Baptista Gomes Dos Santos; Helena Bonciani Nader; Flávio Faloppa
Journal:  Acta Ortop Bras       Date:  2016 Mar-Apr       Impact factor: 0.513

6.  Dermatan sulfate is a player in the transglutaminase 2 interaction network.

Authors:  Grzegorz Wisowski; Ewa M Koźma; Tomasz Bielecki; Adam Pudełko; Krystyna Olczyk
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease.

Authors:  Junghyun Jung; Go Woon Kim; Byungjo Lee; Jong Wha J Joo; Wonhee Jang
Journal:  BMC Med Genomics       Date:  2019-07-11       Impact factor: 3.063

8.  Extracellular matrix alterations in the Peyronie's disease.

Authors:  Marcelo Silva Watanabe; Thérèse Rachel Theodoro; Natália Lima Coelho; Aline Mendes; Monica Luzia Pereira Leonel; Ana Maria Mader; Helena Bonciani Nader; Sidney Glina; Maria Aparecida Silva Pinhal
Journal:  J Adv Res       Date:  2017-06-15       Impact factor: 10.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.